RC
Rangeley Capital, LLC
13F filer · CIK 0001517796Reported Aug 14, 2026
Net seller this quarter
13F portfolio value$109MU.S. long equity reported on 13F
Positions17568 new · 26 closed
Net flow last quarter-$8.87MBuys minus sells
Top 10 positions weight32.1%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 14, 2026175 positions | |||||
| $7.22M | 6.60% | 0.31% | -17.2% | Q4 2024 | |
| $4.68M | 4.28% | Not reported | New | Q2 2026 | |
| $4.09M | 3.73% | 0.81% | -7.2% | Q2 2025 | |
| $4.08M | 3.73% | 1.20% | Not reported | Q4 2024 | |
| $3.16M | 2.89% | 0.13% | -6.0% | Q4 2025 | |
| SSTHOStar Holdings | $2.96M | 2.71% | 2.69% | +18.4% | Q4 2024 |
| $2.58M | 2.36% | 2.53% | +1.1% | Q4 2024 | |
| $2.4M | 2.19% | 0.25% | Not reported | Q4 2024 | |
| $2.08M | 1.90% | 0.13% | -20.0% | Q1 2025 | |
| $1.85M | 1.69% | 0.04% | -1.1% | Q3 2025 | |
| $1.73M | 1.58% | 0.02% | +225.0% | Q3 2025 | |
| $1.72M | 1.57% | 0.22% | -21.6% | Q1 2026 | |
| $1.72M | 1.57% | 0.14% | +273.7% | Q1 2026 | |
| TBTBPHTheravance Biopharma, Inc. | $1.69M | 1.55% | 0.19% | -3.4% | Q2 2025 |
| $1.68M | 1.53% | 1.98% | +248.0% | Q3 2025 | |
| $1.67M | 1.53% | 1.01% | -36.8% | Q1 2026 | |
| $1.65M | 1.51% | 0.32% | +84.4% | Q1 2026 | |
| $1.63M | 1.49% | 0.00% | -87.0% | Q1 2026 | |
| $1.58M | 1.45% | 0.04% | Not reported | Q3 2025 | |
| $1.5M | 1.37% | 0.16% | -20.0% | Q4 2025 | |
| $1.48M | 1.35% | 0.09% | New | Q2 2026 | |
| $1.46M | 1.33% | 0.27% | -21.6% | Q1 2025 | |
| $1.37M | 1.25% | 0.04% | -55.0% | Q4 2024 | |
| $1.36M | 1.24% | 0.00% | Not reported | Q4 2025 | |
| $1.35M | 1.24% | 0.04% | -5.5% | Q4 2025 | |
| $1.27M | 1.16% | Not reported | New | Q2 2026 | |
| $1.19M | 1.08% | Not reported | -9.0% | Q4 2025 | |
| $1.16M | 1.06% | 0.21% | New | Q2 2026 | |
| $1.07M | 0.98% | 0.36% | +9.1% | Q2 2025 | |
| $1.06M | 0.97% | 0.64% | -17.3% | Q4 2024 | |
| $1.03M | 0.94% | 0.11% | -7.1% | Q2 2025 | |
| $915K | 0.84% | 0.06% | Not reported | Q4 2024 | |
| $897K | 0.82% | Not reported | +3.7% | Q3 2025 | |
| DDOMODomo, Inc. | $864K | 0.79% | Not reported | +961.5% | Q1 2026 |
| $845K | 0.77% | Not reported | New | Q2 2026 | |
| $824K | 0.75% | 0.16% | New | Q2 2026 | |
| $745K | 0.68% | 0.33% | +46.7% | Q1 2026 | |
| $743K | 0.68% | 0.16% | -35.3% | Q3 2025 | |
| $731K | 0.67% | 0.08% | New | Q2 2026 | |
| $700K | 0.64% | 2.46% | New | Q2 2026 | |
| $684K | 0.63% | 0.02% | -64.2% | Q4 2024 | |
| $675K | 0.62% | Not reported | New | Q2 2026 | |
| $640K | 0.58% | 0.00% | Not reported | Q3 2025 | |
| DBBCARD. Boral ARC Acquisition I Corp. | $638K | 0.58% | 61150.00% | New | Q2 2026 |
| $633K | 0.58% | Not reported | New | Q2 2026 | |
| $632K | 0.58% | Not reported | Not reported | Q1 2025 | |
| $629K | 0.57% | 0.06% | +57.5% | Q1 2026 | |
| $628K | 0.57% | 0.03% | New | Q2 2026 | |
| $616K | 0.56% | Not reported | +502.0% | Q4 2025 | |
| $609K | 0.56% | 0.13% | +31.2% | Q3 2025 | |
| Q1 2026Reported May 15, 2026133 positions | |||||
| $7.89M | 7.66% | 0.38% | Not reported | Q4 2024 | |
| $4.37M | 4.24% | 0.85% | -14.3% | Q2 2025 | |
| $3.3M | 3.20% | 1.20% | Not reported | Q4 2024 | |
| $2.83M | 2.75% | 0.13% | +10.4% | Q4 2025 | |
| $2.7M | 2.63% | 0.10% | -41.2% | Q4 2024 | |
| $2.37M | 2.31% | 0.35% | -43.4% | Q1 2025 | |
| $2.25M | 2.19% | 0.25% | -40.5% | Q4 2024 | |
| $2.11M | 2.05% | 0.04% | -25.0% | Q3 2025 | |
| LPLEGLeggett & Platt Inc | $2.1M | 2.04% | 0.16% | +56.7% | Q4 2025 |
| SSTHOStar Holdings | $2.07M | 2.02% | 2.27% | +46.5% | Q4 2024 |
| $2.06M | 2.00% | 2.53% | +2.2% | Q4 2024 | |
| $2.03M | 1.97% | 0.16% | Not reported | Q1 2025 | |
| $1.97M | 1.91% | 1.61% | New | Q1 2026 | |
| $1.96M | 1.90% | 0.02% | New | Q1 2026 | |
| $1.9M | 1.85% | 0.06% | -79.6% | Q4 2024 | |
| $1.83M | 1.77% | 0.29% | New | Q1 2026 | |
| KLKZRKezar Life Sciences, Inc. | $1.8M | 1.75% | 3.30% | +182.9% | Q4 2025 |
| $1.7M | 1.65% | 0.20% | +382.0% | Q4 2025 | |
| TBTBPHTheravance Biopharma, Inc. | $1.67M | 1.62% | 0.20% | Not reported | Q2 2025 |
| MCMCWMister Car Wash, Inc. | $1.54M | 1.49% | 0.07% | New | Q1 2026 |
| $1.5M | 1.45% | 0.04% | Not reported | Q3 2025 | |
| $1.45M | 1.41% | 0.05% | +34.0% | Q4 2025 | |
| $1.42M | 1.38% | 0.27% | +11.8% | Q3 2025 | |
| $1.4M | 1.36% | 0.00% | -76.4% | Q4 2025 | |
| $1.32M | 1.29% | 0.78% | +67.7% | Q4 2024 | |
| $1.32M | 1.29% | 0.74% | New | Q1 2026 | |
| $1.24M | 1.20% | 0.03% | New | Q1 2026 | |
| $1.08M | 1.05% | 0.33% | +76.0% | Q2 2025 | |
| $1.07M | 1.04% | Not reported | Not reported | Q4 2024 | |
| KKWKennedy-Wilson Holdings, Inc. | $1.05M | 1.02% | 0.07% | -71.6% | Q4 2025 |
| HHOLXHologic Inc | $983K | 0.95% | 0.01% | New | Q1 2026 |
| $978K | 0.95% | 0.03% | +66.7% | Q4 2024 | |
| $956K | 0.93% | 0.09% | -39.5% | Q1 2025 | |
| $865K | 0.84% | Not reported | +35.9% | Q3 2025 | |
| $840K | 0.82% | 0.17% | New | Q1 2026 | |
| $823K | 0.80% | 0.11% | -1.6% | Q2 2025 | |
| SMSEMSelect Medical Holdings Corp | $815K | 0.79% | 0.04% | -38.3% | Q4 2025 |
| CACWANClearwater Analytics Holdings, Inc. | $662K | 0.64% | Not reported | -65.0% | Q4 2025 |
| $628K | 0.61% | Not reported | +38.9% | Q1 2025 | |
| $601K | 0.58% | 0.28% | -43.8% | Q1 2025 | |
| $549K | 0.53% | Not reported | +162.5% | Q4 2025 | |
| $524K | 0.51% | 0.06% | Not reported | Q4 2024 | |
| $524K | 0.51% | 0.32% | +200.4% | Q4 2025 | |
| GPGPACUGeneral Purpose Acquisition Corp. | $501K | 0.49% | Not reported | Not reported | Q4 2025 |
| $445K | 0.43% | 0.01% | Not reported | Q3 2025 | |
| $444K | 0.43% | 0.03% | -60.0% | Q3 2025 | |
| $442K | 0.43% | 0.04% | New | Q1 2026 | |
| $424K | 0.41% | Not reported | +52.9% | Q3 2025 | |
| $421K | 0.41% | 0.25% | New | Q1 2026 | |
| $420K | 0.41% | Not reported | Not reported | Q3 2025 | |
| Q4 2025Reported Feb 17, 2026113 positions | |||||
| $6.23M | 5.17% | 0.01% | New | Q4 2025 | |
| NRGDENNew Royal Holdco I Inc. | $5.71M | 4.74% | Not reported | New | Q4 2025 |
| $5.15M | 4.28% | 0.30% | -21.7% | Q4 2024 | |
| $5.01M | 4.16% | 0.97% | -6.4% | Q2 2025 | |
| $4.72M | 3.92% | 0.48% | +7.4% | Q3 2025 | |
| $4.69M | 3.90% | 0.62% | -43.1% | Q1 2025 | |
| $4.04M | 3.36% | 0.44% | Not reported | Q4 2024 | |
| ABRNAMAvidity Biosciences, Inc. | $3.9M | 3.23% | 0.04% | New | Q4 2025 |
| RTRPTXRepare Therapeutics Inc. | $3.35M | 2.78% | 3.00% | +99.4% | Q2 2025 |
| KKWKennedy-Wilson Holdings, Inc. | $3.31M | 2.75% | 0.25% | New | Q4 2025 |
| $3.04M | 2.52% | 1.20% | -0.3% | Q4 2024 | |
| $3.03M | 2.51% | 0.17% | -50.5% | Q4 2024 | |
| $2.94M | 2.44% | 3.86% | -8.7% | Q3 2025 | |
| $2.87M | 2.38% | 0.11% | New | Q4 2025 | |
| $2.61M | 2.17% | 0.05% | +4.4% | Q3 2025 | |
| PIPLYMPlymouth Industrial REIT, Inc. | $2.49M | 2.07% | 0.26% | New | Q4 2025 |
| $2.34M | 1.94% | 2.48% | +0.6% | Q4 2024 | |
| $1.97M | 1.64% | 0.50% | -62.6% | Q1 2025 | |
| CACWANClearwater Analytics Holdings, Inc. | $1.93M | 1.60% | Not reported | New | Q4 2025 |
| $1.9M | 1.58% | 0.24% | +177.4% | Q3 2025 | |
| $1.83M | 1.52% | 0.15% | -25.2% | Q1 2025 | |
| $1.77M | 1.47% | 0.46% | -2.2% | Q4 2024 | |
| MTMRSNMersana Therapeutics, Inc. | $1.65M | 1.37% | 1.14% | New | Q4 2025 |
| APAVDLAvadel Pharmaceuticals PLC | $1.64M | 1.36% | 0.08% | New | Q4 2025 |
| $1.62M | 1.35% | 0.04% | +153.8% | Q3 2025 | |
| SSTHOStar Holdings | $1.54M | 1.28% | 1.52% | +5.7% | Q4 2024 |
| LPLEGLeggett & Platt Inc | $1.5M | 1.24% | 0.10% | New | Q4 2025 |
| $1.4M | 1.17% | Not reported | -29.2% | Q2 2025 | |
| $1.4M | 1.16% | 0.30% | -51.7% | Q4 2024 | |
| SMSEMSelect Medical Holdings Corp | $1.2M | 1.00% | 0.07% | New | Q4 2025 |
| $1.19M | 0.99% | 1.09% | +27.0% | Q3 2025 | |
| $1.15M | 0.95% | 0.22% | New | Q4 2025 | |
| $1.08M | 0.90% | Not reported | +53.7% | Q4 2024 | |
| $1.07M | 0.89% | 0.12% | -14.3% | Q2 2025 | |
| $1.06M | 0.88% | 0.10% | -40.3% | Q3 2025 | |
| TTGNATegna Inc | $1.03M | 0.85% | Not reported | +430.0% | Q3 2025 |
| $935K | 0.78% | 0.19% | +1.5% | Q2 2025 | |
| $872K | 0.72% | 0.03% | New | Q4 2025 | |
| $789K | 0.66% | 0.02% | New | Q4 2025 | |
| $686K | 0.57% | 0.49% | +7.3% | Q2 2025 | |
| $671K | 0.56% | 0.02% | Not reported | Q4 2024 | |
| $632K | 0.52% | Not reported | -25.7% | Q3 2025 | |
| GBGBIOGeneration Bio Co. | $558K | 0.46% | 1.46% | New | Q4 2025 |
| SSEMSmart Share Global Ltd | $558K | 0.46% | 0.64% | -23.9% | Q3 2025 |
| KKOREKORE Group Holdings, Inc. | $554K | 0.46% | 0.75% | New | Q4 2025 |
| KLKZRKezar Life Sciences, Inc. | $540K | 0.45% | 1.17% | New | Q4 2025 |
| $539K | 0.45% | 0.01% | -33.3% | Q3 2025 | |
| $517K | 0.43% | 0.03% | +5.5% | Q4 2024 | |
| GPGPACUGeneral Purpose Acquisition Corp. | $501K | 0.42% | Not reported | New | Q4 2025 |
| $496K | 0.41% | 0.06% | Not reported | Q4 2024 | |
| Q3 2025Reported Nov 14, 2025117 positions | |||||
| $6.65M | 5.75% | 0.34% | -34.2% | Q4 2024 | |
| $6.04M | 5.23% | 0.38% | +3.8% | Q4 2024 | |
| $5.92M | 5.13% | 0.98% | +0.1% | Q1 2025 | |
| $5.47M | 4.73% | 1.04% | -21.7% | Q2 2025 | |
| WWOWWideOpenWest, Inc. | $4.89M | 4.23% | 1.11% | +18.7% | Q4 2024 |
| $4.64M | 4.02% | 0.44% | New | Q3 2025 | |
| $4.09M | 3.54% | 0.64% | -9.4% | Q1 2025 | |
| $3.81M | 3.30% | 0.44% | -2.9% | Q4 2024 | |
| $3.53M | 3.05% | 1.21% | -2.5% | Q4 2024 | |
| $3.3M | 2.85% | 4.23% | New | Q3 2025 | |
| $2.86M | 2.47% | 2.47% | +1.0% | Q4 2024 | |
| $2.68M | 2.32% | 0.10% | -25.3% | Q1 2025 | |
| $2.44M | 2.11% | Not reported | -6.8% | Q2 2025 | |
| $2.44M | 2.11% | 0.63% | +10.0% | Q4 2024 | |
| $2.08M | 1.80% | 0.47% | Not reported | Q4 2024 | |
| $1.76M | 1.52% | 0.05% | New | Q3 2025 | |
| $1.66M | 1.43% | 0.20% | +50.2% | Q1 2025 | |
| SSTHOStar Holdings | $1.46M | 1.26% | 1.37% | +2.9% | Q4 2024 |
| $1.27M | 1.10% | 0.09% | Not reported | Q2 2025 | |
| $1.16M | 1.00% | 0.06% | Not reported | Q4 2024 | |
| $1.14M | 0.99% | 0.06% | New | Q3 2025 | |
| RTRPTXRepare Therapeutics Inc. | $1.14M | 0.98% | 1.50% | +81.8% | Q2 2025 |
| $1.13M | 0.97% | 0.12% | -16.7% | Q4 2024 | |
| $1.06M | 0.92% | 0.14% | +3.5% | Q2 2025 | |
| $1.04M | 0.90% | 0.07% | -16.2% | Q4 2024 | |
| GIGSRTGSR III Acquisition Corp. | $1.04M | 0.90% | Not reported | +809.1% | Q2 2025 |
| $1.03M | 0.89% | Not reported | New | Q3 2025 | |
| $1.01M | 0.87% | 0.19% | +73.3% | Q2 2025 | |
| $935K | 0.81% | 0.95% | New | Q3 2025 | |
| $852K | 0.74% | Not reported | New | Q3 2025 | |
| SSEMSmart Share Global Ltd | $845K | 0.73% | 0.85% | New | Q3 2025 |
| CCCCCMColumbus Circle Capital Corp I | $840K | 0.73% | Not reported | New | Q3 2025 |
| $837K | 0.72% | 0.18% | New | Q3 2025 | |
| SHSHCOSoho House & Co Inc. | $825K | 0.71% | 0.05% | +237.7% | Q1 2025 |
| SISBXDSilverBox Corp IV | $806K | 0.70% | Not reported | +670.3% | Q2 2025 |
| 8ETNB89bio, Inc. | $794K | 0.69% | 0.04% | New | Q3 2025 |
| SOSOCSable Offshore Corp. | $733K | 0.63% | 0.04% | +68.0% | Q2 2025 |
| $703K | 0.61% | 0.09% | New | Q3 2025 | |
| $679K | 0.59% | 0.46% | +10.0% | Q2 2025 | |
| $658K | 0.57% | 0.03% | +7.8% | Q4 2024 | |
| MOMURAMural Oncology plc | $631K | 0.55% | 1.76% | +555.7% | Q2 2025 |
| $627K | 0.54% | 0.02% | Not reported | Q4 2024 | |
| $599K | 0.52% | 0.13% | New | Q3 2025 | |
| $597K | 0.52% | Not reported | Not reported | Q4 2024 | |
| $550K | 0.48% | 0.00% | New | Q3 2025 | |
| $538K | 0.47% | Not reported | Not reported | Q4 2024 | |
| SSCPHScpharmaceuticals Inc. | $532K | 0.46% | 0.18% | New | Q3 2025 |
| $523K | 0.45% | 0.02% | New | Q3 2025 | |
| $509K | 0.44% | 0.01% | New | Q3 2025 | |
| $486K | 0.42% | Not reported | New | Q3 2025 | |
Premium opens every quarter this fund has filed